agilon health, inc. (AGL) Balance Sheet
AGL balance sheet, 2025
December 31, 2025 · U.S. dollars$1.27B assets = $1.14B liabilities + $126.7M equity
Both columns are drawn to the same scale: what AGL owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AGL financial health
Descriptive bands, not a rating. Fiscal 2025.
AGL balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $402.8M2019 | $1.27B2025 | +21.1%/yr | |
| Total liabilities | $634.8M2019 | $1.14B2025 | +10.3%/yr | |
| Shareholders’ equity | −$232.0M2019 | $126.7M2025 | — | |
| Cash & short-term investments | $123.6M2019 | $285.1M2025 | +14.9%/yr | |
| Total debt | $77.9M2019 | $36.8M2025 | −11.7%/yr | |
| Net cash (debt) | $45.7M2019 | $248.3M2025 | +$202.6M | |
| Working capital | $45.9M2019 | $20.2M2025 | −$25.7M | |
| Book value per share | −$15.112019 | $7.652025 | — | |
| Current ratio | 1.232019 | 1.022025 | −0.21 | |
| Debt / equity | 0.052021 | 0.292025 | +0.24 | |
| Shares outstanding | 15.4M2019 | 16.6M2025 | +1.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AGL assets
AGL liabilities and equity
AGL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AGL balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $285.1M | $405.6M | $495.1M | $877.2M | $1.05B | $106.8M | $123.6M |
| Cash & equivalents | $173.7M | $193.9M | $114.3M | $465.3M | $1.05B | $106.8M | $123.6M |
| Short-term investments | $111.4M | $211.7M | $380.8M | $411.9M | $0 | — | — |
| Receivables | $673.8M | $1.02B | $942.5M | $492.4M | $293.4M | $144.6M | $93.3M |
| Inventory | $0 | $0 | −$42.5M | $10.6M | $1 | $1 | $1 |
| Other current assets | $137.8M | $35.1M | $85.0M | $71.1M | $19.0M | $42.8M | $28.6M |
| Total current assets | $1.10B | $1.46B | $1.48B | $1.45B | $1.37B | $294.2M | $245.5M |
| Property, plant & equipment (net) | $25.4M | $37.0M | $41.0M | $32.0M | $20.9M | $16.0M | $18.8M |
| Goodwill & intangible assets | $107.3M | $96.9M | $87.9M | $21.0M | $96.9M | $102.0M | $112.7M |
| Long-term investments | $59.8M | $61.8M | $44.8M | $17.4M | $6.7M | $8.5M | $0 |
| Other non-current assets | $0 | $80.6M | $87.1M | $175.9M | $94.5M | $25.6M | $25.7M |
| Total assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B | $446.4M | $402.8M |
| Liabilities | |||||||
| Accounts payable | $1.06B | $1.15B | $968.1M | $478.2M | $348.7M | $260.1M | $188.3M |
| Short-term debt | $19.2M | $2.5M | $9.1M | $5.0M | $8.3M | $3.0M | $3.0M |
| Deferred revenue | — | — | −$970.9M | −$346.7M | −$352.0M | — | — |
| Total current liabilities | $1.08B | $1.15B | $977.2M | $535.1M | $357.0M | $266.8M | $199.6M |
| Long-term debt | $15.8M | $34.9M | $32.3M | $38.5M | $43.4M | $64.7M | $67.1M |
| Lease obligations | $1.8M | $6.6M | $10.9M | $9.9M | $7.9M | $5.5M | $7.7M |
| Other long-term liabilities | $52.3M | $76.1M | $70.4M | $83.3M | $94.3M | $399.6M | $368.1M |
| Total liabilities | $1.14B | $1.26B | $1.08B | $656.9M | $494.7M | $731.1M | $634.8M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $4.1M | $4.1M | $4.1M | $4.1M | $4.0M | $2.5M | $2.5M |
| Retained earnings (deficit) | −$1.98B | −$1.59B | −$1.33B | −$1.06B | −$957.7M | −$551.2M | −$491.1M |
| Accumulated other comprehensive income | $916,000 | −$88,000 | −$2.3M | −$5.6M | $0 | −$7.3M | −$4.8M |
| Minority interest | — | $0 | −$818,000 | −$611,000 | −$300,000 | — | — |
| Total shareholders' equity | $126.7M | $471.0M | $661.8M | $1.04B | $1.09B | −$284.7M | −$232.0M |
| Key figures | |||||||
| Total debt | $36.8M | $44.0M | $52.3M | $52.6M | $59.6M | $73.2M | $77.9M |
| Net cash (debt) | $248.3M | $361.6M | $442.8M | $824.6M | $995.2M | $33.6M | $45.7M |
| Working capital | $20.2M | $305.8M | $502.9M | $916.2M | $1.01B | $27.4M | $45.9M |
| Tangible book value | $19.5M | $374.0M | $573.9M | $1.02B | $995.0M | −$386.7M | −$344.7M |
| Book value per share | $7.65 | $28.65 | $40.46 | $63.78 | $73.20 | −$18.50 | −$15.11 |
| Shares outstanding | 16.6M | 16.4M | 16.4M | 16.3M | 14.9M | 15.4M | 15.4M |
| Current ratio | 1.02 | 1.27 | 1.51 | 2.71 | 3.83 | 1.10 | 1.23 |
| Quick ratio | 0.89 | 1.23 | 1.47 | 2.56 | 3.78 | 0.94 | 1.09 |
| Debt / equity | 0.29 | 0.09 | 0.08 | 0.05 | 0.05 | — | — |
| Equity / assets | 10.0% | 27.2% | 38.0% | 61.3% | 68.8% | −63.8% | −57.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $185.6M | $231.4M | $285.1M | $310.9M | $327.0M | $368.8M | $405.6M | $398.6M | $408.0M | $425.9M | $495.1M | $564.2M |
| Cash & equivalents | $107.2M | $140.0M | $173.7M | $171.7M | $171.4M | $138.6M | $193.9M | $153.8M | $116.3M | $118.5M | $114.3M | $168.3M |
| Short-term investments | $78.4M | $91.4M | $111.4M | $139.2M | $155.6M | $230.1M | $211.7M | $244.8M | $291.6M | $307.4M | $380.8M | $395.9M |
| Receivables | $1.06B | $899.7M | $673.8M | $947.2M | $1.05B | $1.24B | $1.02B | $1.37B | $1.44B | $1.57B | $942.5M | $1.35B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $10.2M |
| Other current assets | $173.1M | $190.0M | $137.8M | $80.0M | $78.5M | $42.4M | $35.1M | $44.9M | $39.0M | $39.8M | $42.5M | $36.5M |
| Total current assets | $1.42B | $1.32B | $1.10B | $1.34B | $1.45B | $1.65B | $1.46B | $1.81B | $1.88B | $2.04B | $1.48B | $1.96B |
| Property, plant & equipment (net) | $29.4M | $30.1M | $25.4M | $30.1M | $36.2M | $37.8M | $37.0M | $39.7M | $40.4M | $40.6M | $41.0M | $40.8M |
| Goodwill & intangible assets | $60.1M | $62.4M | $107.3M | $99.4M | $89.7M | $92.3M | $96.9M | $97.5M | $99.0M | $96.2M | $87.9M | $155.0M |
| Long-term investments | $65.1M | $72.1M | $59.8M | $90.5M | $77.9M | $73.0M | $61.8M | $53.9M | $51.0M | $53.7M | $44.8M | $39.2M |
| Other non-current assets | $18.2M | $19.0M | $0 | $38.3M | $56.4M | $79.0M | $80.6M | $88.5M | $88.9M | $89.1M | $87.1M | $86.4M |
| Total assets | $1.59B | $1.50B | $1.27B | $1.60B | $1.71B | $1.93B | $1.73B | $2.09B | $2.16B | $2.32B | $1.74B | $2.28B |
| Liabilities | ||||||||||||
| Accounts payable | $274.9M | $1.26B | $1.06B | $145.5M | $1.21B | $1.34B | $1.15B | $1.41B | $1.38B | $1.52B | $968.1M | $1.30B |
| Short-term debt | $14.9M | $14.7M | $19.2M | $35.0M | $34.9M | $34.9M | $2.5M | $0 | $8.8M | $7.5M | $9.1M | $5.0M |
| Deferred revenue | — | — | — | — | — | — | — | — | −$1.38B | −$1.52B | −$970.9M | −$1.30B |
| Total current liabilities | $1.31B | $1.27B | $1.08B | $1.24B | $1.25B | $1.37B | $1.15B | $1.41B | $1.39B | $1.53B | $977.2M | $1.30B |
| Long-term debt | $15.4M | $15.3M | $15.8M | $0 | $0 | $0 | $34.9M | $34.9M | $27.4M | $29.8M | $32.3M | $34.8M |
| Lease obligations | $3.2M | $3.4M | $1.8M | $2.2M | $6.4M | $7.1M | $6.6M | $9.0M | $10.1M | $10.6M | $10.9M | $12.0M |
| Other long-term liabilities | $36.1M | $35.9M | $52.3M | $50.3M | $54.9M | $57.9M | $76.1M | $72.5M | $72.8M | $71.5M | $70.4M | $70.4M |
| Total liabilities | $1.36B | $1.32B | $1.14B | $1.29B | $1.30B | $1.43B | $1.26B | $1.52B | $1.49B | $1.63B | $1.08B | $1.41B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $168,000 | $166,000 | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M |
| Retained earnings (deficit) | −$1.91B | −$1.93B | −$1.98B | −$1.79B | −$1.68B | −$1.57B | −$1.59B | −$1.48B | −$1.36B | −$1.33B | −$1.33B | −$1.10B |
| Accumulated other comprehensive income | $154,000 | $479,000 | $916,000 | $880,000 | $787,000 | $543,000 | −$88,000 | $301,000 | −$2.4M | −$2.7M | −$2.3M | −$6.2M |
| Total shareholders' equity | $227.5M | $181.4M | $126.7M | $306.1M | $408.9M | $500.3M | $471.0M | $574.9M | $676.6M | $689.3M | $661.8M | $872.4M |
| Key figures | ||||||||||||
| Total debt | $33.4M | $33.4M | $36.8M | $37.1M | $41.4M | $42.0M | $44.0M | $43.9M | $46.2M | $48.0M | $52.3M | $51.8M |
| Net cash (debt) | $152.2M | $198.0M | $248.3M | $273.7M | $285.6M | $326.7M | $361.6M | $354.7M | $361.8M | $378.0M | $442.8M | $512.5M |
| Working capital | $106.2M | $48.8M | $20.2M | $98.1M | $203.6M | $276.0M | $305.8M | $402.6M | $496.7M | $510.2M | $502.9M | $655.3M |
| Tangible book value | $167.4M | $119.0M | $19.5M | $206.7M | $319.2M | $407.9M | $374.0M | $477.3M | $577.7M | $593.1M | $573.9M | $717.3M |
| Book value per share | $13.22 | $10.89 | $7.64 | $18.46 | $24.70 | $30.29 | $28.57 | $34.92 | $41.13 | $42.14 | $40.46 | $53.75 |
| Shares outstanding | 17.2M | 16.7M | 16.6M | 16.6M | 16.6M | 16.5M | 16.5M | 16.5M | 16.5M | 16.4M | 16.4M | 16.2M |
| Current ratio | 1.08 | 1.04 | 1.02 | 1.08 | 1.16 | 1.20 | 1.27 | 1.29 | 1.36 | 1.33 | 1.51 | 1.50 |
| Quick ratio | 0.95 | 0.89 | 0.89 | 1.01 | 1.10 | 1.17 | 1.23 | 1.25 | 1.33 | 1.31 | 1.47 | 1.47 |
| Debt / equity | 0.15 | 0.18 | 0.29 | 0.12 | 0.10 | 0.08 | 0.09 | 0.08 | 0.07 | 0.07 | 0.08 | 0.06 |
| Equity / assets | 14.3% | 12.1% | 10.0% | 19.2% | 23.9% | 25.9% | 27.2% | 27.5% | 31.3% | 29.8% | 38.0% | 38.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 25, 2026); data from EODHD.
AGL financial position
At the end of fiscal 2025 (December 31, 2025), agilon health had total assets of $1.3 billion (down 26.7% from a year earlier), total liabilities of $1.1 billion and shareholders' equity of $126.7 million. It held $285.1 million in cash and short-term investments against $36.8 million of debt, a net cash position of $248.3 million. Its current ratio was 1.02. In the latest quarter (ended June 30, 2026) total assets were $1.6 billion and equity $227.5 million.
Related: AGL income statement, AGL cash flow statement, AGL key metrics. See the AGL stock overview for the latest quote and news.
AGL balance sheet FAQ
What are agilon health's total assets?
agilon health reported total assets of $1.3 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.7 billion a year earlier.
How much debt does agilon health have?
agilon health had $36.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.29.
How much cash does agilon health have?
agilon health held $285.1 million in cash and short-term investments at the end of fiscal 2025; with $36.8 million of debt that is net cash of $248.3 million.
What is agilon health's book value?
agilon health's shareholders' equity (book value) was $126.7 million at the end of fiscal 2025, or $7.65 per share.
What is agilon health's current ratio?
agilon health had current assets of $1.1 billion and current liabilities of $1.1 billion, a current ratio of 1.02 (it can cover its short-term obligations).
How much goodwill does agilon health have?
agilon health carried $107.3 million of goodwill and intangible assets, 8.4% of total assets, at the end of fiscal 2025.